Enfusion Statistics Share Statistics Enfusion has 94.8M
shares outstanding. The number of shares has increased by 1.71%
in one year.
Shares Outstanding 94.8M Shares Change (YoY) 1.71% Shares Change (QoQ) 0% Owned by Institutions (%) 99.99% Shares Floating 46.32M Failed to Deliver (FTD) Shares 256,308 FTD / Avg. Volume 21.86%
Short Selling Information The latest short interest is 2.95M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.95M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.64
Valuation Ratios The PE ratio is 335.84 and the forward
PE ratio is 29.08.
Enfusion's PEG ratio is
-4.14.
PE Ratio 335.84 Forward PE 29.08 PS Ratio 4.7 Forward PS 3.7 PB Ratio 12.95 P/FCF Ratio 30.54 PEG Ratio -4.14
Financial Ratio History Enterprise Valuation Enfusion has an Enterprise Value (EV) of 913.9M.
EV / Sales 4.53 EV / EBITDA 148.48 EV / EBIT 26.35 EV / FCF 29.44
Financial Position The company has a current ratio of 3.42,
with a Debt / Equity ratio of 0.28.
Current Ratio 3.42 Quick Ratio 3.42 Debt / Equity 0.28 Debt / EBITDA 3.3 Debt / FCF 0.65 Interest Coverage 0
Financial Efficiency Return on Equity is 3.86% and Return on Invested Capital is 1.93%.
Return on Equity 3.86% Return on Assets 1.97% Return on Invested Capital 1.93% Revenue Per Employee $176.39K Profits Per Employee $2.47K Employee Count 1,143 Asset Turnover 1.41 Inventory Turnover n/a
Taxes Income Tax 4.57M Effective Tax Rate 61.79%
Stock Price Statistics The stock price has increased by 31.06% in the
last 52 weeks. The beta is 0.93, so Enfusion's
price volatility has been higher than the market average.
Beta 0.93 52-Week Price Change 31.06% 50-Day Moving Average 11.1 200-Day Moving Average 9.83 Relative Strength Index (RSI) 42.68 Average Volume (20 Days) 1,172,308
Income Statement In the last 12 months, Enfusion had revenue of 201.61M
and earned 2.82M
in profits. Earnings per share was 0.02.
Revenue 201.61M Gross Profit 136.74M Operating Income 6.16M Net Income 2.82M EBITDA 6.16M EBIT 6.16M Earnings Per Share (EPS) 0.02
Full Income Statement Balance Sheet The company has 54.48M in cash and 20.31M in
debt, giving a net cash position of 34.17M.
Cash & Cash Equivalents 54.48M Total Debt 20.31M Net Cash 34.17M Retained Earnings -170.11M Total Assets 143.26M Working Capital 66.19M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 34.68M
and capital expenditures -3.63M, giving a free cash flow of 31.05M.
Operating Cash Flow 34.68M Capital Expenditures -3.63M Free Cash Flow 31.05M FCF Per Share 0.34
Full Cash Flow Statement Margins Gross margin is 67.82%, with operating and profit margins of 3.05% and 1.4%.
Gross Margin 67.82% Operating Margin 3.05% Pretax Margin 3.66% Profit Margin 1.4% EBITDA Margin 3.05% EBIT Margin 3.05% FCF Margin 15.4%
